ANGIOTENSIN-RESPONSIVE ADRENAL GLOMERULOSA CELL-PROTEINS - CHARACTERIZATION BY PROTEASE MAPPING, SPECIES COMPARISON, AND SPECIFIC ANGIOTENSIN RECEPTOR ANTAGONISTS
Me. Elliott et al., ANGIOTENSIN-RESPONSIVE ADRENAL GLOMERULOSA CELL-PROTEINS - CHARACTERIZATION BY PROTEASE MAPPING, SPECIES COMPARISON, AND SPECIFIC ANGIOTENSIN RECEPTOR ANTAGONISTS, Endocrinology, 138(6), 1997, pp. 2530-2536
Angiotensin II (AngII)-stimulated aldosterone synthesis is mediated by
the AngII type 1 (AT(1)) receptor and requires ongoing protein synthe
sis. Hormonally-stimulated turnover of a family of 28- to 30-kDa prote
ins (p30, or steroidogenic acute regulatory proteins) has been linked
to enhanced steroid synthesis in several tissues. Our previous work sh
owed that AngII, dibutyryl cAMP, potassium, and atrial natriuretic pep
tide affected labeling of a group of eight proteins (four of 28 kDa an
d four of 30 kDa) in bovine adrenal glomerulosa cells. This report ext
ends our findings in three ways: I) The eight [S-35]-methionine-labele
d p30 proteins in bovine cells were compared with each other by chymot
ryptic peptide mapping. Similarity in maps indicated that the eight pr
oteins share a common primary structure. 2)Dibutyryl cAMP treatment of
rat adrenal glomerulosa cells affected the levels of Four 28-kDa prot
eins and one 35-kDa protein, whereas AngII affected two of the 28-kDa
proteins. There were no responsive 80-kDa proteins in rats comparable
with those seen in bovine cells. These results indicate a species diff
erence in the affected proteins. 3) The AT(1) receptor antagonist, los
artan, inhibited the effects of AngII on aldosterone synthesis and tur
nover of the p30 proteins in bovine adrenal glomerulosa cells. PD12331
9, an antagonist specific for the AngII type 2 receptor, did not block
AngII-stimulated aldosterone synthesis and had much less effect on p3
0 protein labeling than did losartan. These results add to the growing
body of evidence that this family of p30 or steroidogenic acute regul
atory proteins plays a role in the acute regulation of steroidogenesis
by a wide variety of stimulatory hormones in several tissues and spec
ies. In addition, Iosartan's inhibition of AngII's effects on the p30
proteins is consistent with a key role for these proteins in processes
linking occupation of the AT, receptor to stimulation of aldosterone
synthesis.